C82.9A
Follicular lymphoma, unspecified, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of blood cancer that begins in the lymphatic system, specifically in the lymph nodes. When diagnosed as 'unspecified' and 'in remission,' it means that the exact subtype of follicular lymphoma hasn't been clearly identified, but the disease is currently not active and symptoms are controlled or absent. Remission indicates that the signs and symptoms of the disease have reduced or disappeared following treatment, and regular monitoring is necessary to ensure it remains in remission.
Causes & Symptoms
Clinical Causes: Genetic mutations within lymphocytes (a type of white blood cell) Age-related changes, with higher incidences in older adults Family history of lymphomas or other blood cancers Exposure to certain chemicals or radiation Immune system deficiencies or autoimmune disorders
Key Symptoms: Painless swelling of lymph nodes in the neck, armpits, or groin Unexplained weight loss Persistent fatigue Fever that comes and goes Night sweats Abdominal discomfort or swelling Feeling of fullness or early satiety Itching without an apparent cause
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of physical examinations, blood tests, imaging studies such as PET scans or CT scans, and a biopsy of lymph node tissue. The biopsy helps confirm the presence of lymphoma cells and determine the specific subtype. Once diagnosed, further tests may classify the lymphoma, assess its stage, and estimate the prognosis. When the disease is in remission, it means that treatment has successfully controlled or eliminated signs of disease, but ongoing follow-up is essential to detect any potential recurrence.
Treatment Protocols: Treatment options for follicular lymphoma can include chemotherapy, immunotherapy, targeted therapy, radiation therapy, or a combination of these methods. The approach depends on the stage of the disease, the patient's overall health, and specific features of the lymphoma. In cases where the lymphoma is in remission, a 'watch and wait' strategy may be adopted, with regular monitoring to detect any signs of relapse early. Patients in remission are often advised to maintain follow-up appointments and reports of new symptoms to their healthcare providers.
Clinical Advice & FAQs
Billing Guidance
Is C82.9A a billable ICD-10 code?
Yes, C82.9A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.9A?
Clinical documentation must specify the nature of Follicular lymphoma, unspecified, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference